Clinical trials
Terminated Phase 3 Seizures trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jazz Pharmaceuticals | 2 |
| SK Life Science, Inc. | 2 |
| Xenon Pharmaceuticals Inc. | 2 |
| Abbott | 1 |
| Eisai Inc. | 1 |
| GlaxoSmithKline | 1 |
| Kamuzu University of Health Sciences | 1 |
| Marinus Pharmaceuticals | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Population Health Research Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seizures | 18 |
| Epilepsy | 13 |
| Epilepsies, Partial | 5 |
| Epilepsies, Myoclonic | 4 |
| Brain Diseases | 3 |
| Central Nervous System Diseases | 2 |
| Disease | 2 |
| Drug Resistant Epilepsy | 2 |
| Epileptic Syndromes | 2 |
| Nervous System Diseases | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.